AbbVie Receives Positive CHMP Opinion for Crohn’s Disease Treatment March 1, 2023 AutoBot News 0 CHMP recommended the approval of AbbVie’s RINVOQ (upadacitinib) as a treatment for adults with moderate-to-severe Crohn’s disease.